Tuberculosis Vaccine Market Statistics, Global Analysis, Demand, Revenue and Trend Analysis Research Report by 2018 - 2026
Tuberculosis (TB) is a highly contagious disease caused by the bacteria Mycobacterium tuberculosis, which is spread primarily by direct contact between people. It causes multisystem illness, which can lead to the sick person's death. Latent TB, in which the infected individual shows no symptoms, and active TB, in which the infected person has clinical symptoms of TB, are the two forms of TB that are usually seen. Fever, night sweats, cough, weight loss, hemoptysis (coughing up blood-stained sputum), exhaustion, chest pain, and shortness of breath are some of the clinical symptoms and indicators of tuberculosis.
Tuberculosis is the infectious disease that causes the greatest number of deaths worldwide. According to the World Health Organization's (WHO) publication on tuberculosis (TB), 10.4 million people became infected with the disease in 2016 and 1.7 million people died from it. More than 95% of tuberculosis deaths happen in low- and middle-income countries. A total of 0.4 million persons infected with HIV died as a result of tuberculosis. Such a large number of patients indicates the disease's vastness and the urgent need for vaccines around the world. As a result, the launch of a tuberculosis vaccine would generate enormous income, propelling the Tuberculosis Vaccine Market forward.
According to the World Health Organization, approximately 600,000 new instances of rifampicin resistance, the most effective first-line medication, were reported in 2017, with around 490,000 of those having MDR-TB. According to a global research on tuberculosis vaccine 2018, if adequate measures are not done by 2050, MDR-TB alone might cost the world US$ 16.7 trillion. With today's TB medications, drug toxicity is a worry due to high daily doses and protracted treatment periods. Although the cost of tuberculosis medicine is not a major worry in poor nations because to government backing and free medication, it is a major concern in affluent countries like the United States and Europe.
Comments
Post a Comment